Numis Securities Ltd Reaffirms “Buy” Rating for Emis Group Plc (EMIS)
Emis Group Plc (LON:EMIS)‘s stock had its “buy” rating reaffirmed by investment analysts at Numis Securities Ltd in a note issued to investors on Friday. They currently have a GBX 1,150 ($14.85) price target on the stock. Numis Securities Ltd’s price target suggests a potential upside of 25.14% from the stock’s current price.
Shares of Emis Group Plc (LON:EMIS) traded down 1.45% on Friday, reaching GBX 919.00. 72,632 shares of the company traded hands. The company’s market capitalization is GBX 577.55 million. The firm has a 50-day moving average of GBX 958.84 and a 200-day moving average of GBX 925.81. Emis Group Plc has a 52-week low of GBX 786.97 and a 52-week high of GBX 1,025.00.
Emis Group Plc (LON:EMIS) last announced its earnings results on Thursday, August 31st. The company reported $0.13 EPS for the quarter. Emis Group Plc had a return on equity of 14.91% and a net margin of 10.88%. On average, equities research analysts forecast that Emis Group Plc will post $48.90 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Numis Securities Ltd Reaffirms “Buy” Rating for Emis Group Plc (EMIS)” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/09/09/numis-securities-ltd-reaffirms-buy-rating-for-emis-group-plc-emis.html.
Emis Group Plc Company Profile
EMIS Group plc provides healthcare software, information technology and related services in the United Kingdom. The Company operates through three segments: Primary & Community Care; Community Pharmacy, and Secondary & Specialist Care. The Company serves various healthcare markets under the EMIS Health brand.
Receive News & Ratings for Emis Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emis Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.